Reduction Mammaplasty in Younger Patients: An Evidence-Based Approach to Treatment.
Plast Aesthet Nurs (Phila)
; 43(4): 203-209, 2023.
Article
em En
| MEDLINE
| ID: mdl-37774166
ABSTRACT
Macromastia is a common condition that can lead to physical pain, emotional burden, and behavioral impairment, with significant decrements in quality of life. Reduction mammaplasty offers the only effective treatment of symptomatic macromastia, and patients experience significant improvements in their physical and psychosocial health through surgical correction. Although symptoms typically arise during adolescence, most women seeking surgical intervention do not undergo reduction mammaplasty until their fifth decade of life. Providers often delay surgery due to speculative concerns about emotional immaturity, postoperative breast regrowth, and future lactation performance. The strict guidelines related to age and body mass index imposed by insurance companies further restrict the options available to younger patients with macromastia. This review offers an evidence-based approach to treating macromastia in younger patients. After more than 15 years of treatment and research centered on adolescents and young adults with macromastia led by the senior author (B.I.L.), a pediatric plastic surgeon, we have found that reduction mammaplasty is a safe and effective treatment option for this patient population. It is our hope that our work will enable care providers to make data-supported decisions when treating younger patients with symptomatic macromastia.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Qualidade de Vida
/
Mamoplastia
Tipo de estudo:
Guideline
Limite:
Adolescent
/
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Plast Aesthet Nurs (Phila)
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Marrocos